http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0018417-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 |
| filingDate | 1980-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1982-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1982-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0018417-B1 |
| titleOfInvention | Novel piperidine derivatives and pharmaceutical compositions containing them |
| abstract | Novel compounds represented by the following general formula: (FORMULA) wherein Ar represents naphthyl, phenyl, or substituted phenyl, Q represents -C-, -CH2, or-CH- (FORMULA) (wherein R1 represents hydrogen, alkyl, alkanoyl or alkoxycarbonyl, R represents hydrogen or alkyl Z represents substituted benzimidazolinyl, and the broken line in the piperidine ring indicates that 3- and 4-positions of the piperidine ring are saturated or indicates a double bond therebetween. Said compounds and the medically acceptable acid addition salts thereof show a hypotensive action, thus being useful as medicines. |
| priorityDate | 1978-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 296.